-
Orphan-Drug-Designation finalised
Oncoscience | June 30th, 2004
Oncoscience AG announces that it finalised the Orphan-Drug-Designation for its monoclonal antibody h-R3 (Theraloc) with ...
Oncoscience AG announces that it finalised the Orphan-Drug-Designation for its monoclonal antibody h-R3 (Theraloc) with ...